Copyright
©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. Feb 6, 2017; 8(1): 81-89
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.81
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.81
After completion of management | FIQoLS 1 Median (IQR) | FIQoLS 2 Median (IQR) | FIQoLS 3 Median (IQR) | FIQoLS 4 Median (IQR) |
IRAT pathway | 3.9 (2.2- 4.0) | 2.9 (1.8 3.8) | 3.9 (2.3-4.1) | 3.0 (1.8-3.8) |
Standard care pathway | 3.6 (2.4-4.0) | 3.8 (1.7-4.0) | 3.5 (2.1-3.9) | 2.3 (1.6-3.7) |
P value | 0.51 | 0.92 | 0.18 | 0.87 |
- Citation: Hussain ZI, Lim M, Stojkovic S. Role of clinical pathway in improving the quality of care for patients with faecal incontinence: A randomised trial. World J Gastrointest Pharmacol Ther 2017; 8(1): 81-89
- URL: https://www.wjgnet.com/2150-5349/full/v8/i1/81.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v8.i1.81